This is a Validated Antibody Database (VAD) review about rat Ubc, based on 7 published articles (read how Labome selects the articles), using Ubc antibody in all methods. It is aimed to help Labome visitors find the most suited Ubc antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
| mouse monoclonal (P4G7) |
| BioLegend Ubc antibody (Biolegend, 838703) was used in western blot on mouse samples at 1:1000 (fig s4). Nat Commun (2022) ncbi |
| mouse monoclonal (P4G7) |
| BioLegend Ubc antibody (BioLegend, P4G7) was used in western blot on human samples at 1:1000 (fig 1d). Nat Commun (2021) ncbi |
| mouse monoclonal (P4G7) |
| In order to elucidate the mechanisms by which ARHGAP36 blocks protein kinase A signaling, BioLegend Ubc antibody (Covance, P4G7) was used in western blot on human samples at 1:500 (fig 6a). Nat Commun (2016) ncbi |
| mouse monoclonal (P4G7) |
| BioLegend Ubc antibody (Covance, P4G7) was used in western blot on human samples (fig 2d). Mol Neurobiol (2016) ncbi |
Invitrogen
| domestic rabbit polyclonal |
| Invitrogen Ubc antibody (Fisher Scientific, PA1-10023) was used in immunohistochemistry - free floating section on mouse samples at 1:2000 (fig s7b). Mol Neurodegener (2022) ncbi |
| domestic rabbit polyclonal |
| In order to explore the contribution of STEP61 to the therapeutic effects of D-serine in patients with schizophrenia, Invitrogen Ubc antibody (Thermo Scientific, PA1-10023) was used in western blot on rat samples at 1:5000 (fig 6b). Mol Neurobiol (2018) ncbi |
| domestic rabbit polyclonal |
| In order to elucidate how the CMG complex is displaced from chromatin, Invitrogen Ubc antibody (Pierce, PA1-187) was used in western blot on Xenopus laevis samples (fig 1f). Mol Cell Biol (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
